| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.1B | $4.0B | $3.9B | $3.7B | $3.4B | $3.1B | $3.8B | $3.8B |
| Cost of Revenue | $8.9B | $2.3B | $2.3B | $2.3B | $2.0B | $1.8B | $2.2B | $2.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $4.3B | $1.1B | $1.0B | $0.9B | $0.9B | $0.8B | $1.0B | $0.9B |
| Operating Income | $2.7B | $0.6B | $0.6B | $0.4B | $0.4B | $0.4B | $0.6B | $0.6B |
| Net Income | $2.1B | $2.1B | $1.4B | $1.1B | $1.1B | $-1.2B | $0.4B | $0.4B |
| EPS (Basic) | $7.33 | $1.67 | $1.42 | $0.93 | $1.05 | $1.05 | $1.49 | $1.37 |
| EPS (Diluted) | $7.28 | $1.66 | $1.41 | $0.93 | $1.04 | $1.04 | $1.47 | $1.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.7B | $22.4B | $21.8B | $21.5B | $21.2B | $18.1B | $20.9B | $20.1B |
| Current Assets | $6.0B | $6.0B | $5.6B | $5.5B | $4.7B | $5.1B | $4.8B | $4.7B |
| Cash & Equivalents | $0.6B | $1.3B | $0.9B | $0.6B | $0.4B | $1.3B | $0.2B | $0.1B |
| Total Liabilities | $14.9B | $13.6B | $13.8B | $14.2B | $14.0B | $11.9B | $12.1B | $12.0B |
| Current Liabilities | $5.5B | $4.8B | $4.3B | $4.2B | $3.6B | $2.9B | $3.6B | $3.7B |
| Stockholders' Equity | $9.8B | $8.8B | $8.0B | $7.2B | $7.2B | $6.2B | $8.7B | $8.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.0B | $2.8B | $2.4B | $1.8B | $2.1B | $1.9B | $2.4B | $2.3B |
| Investing Cash Flow | $-2.7B | $-0.4B | $-1.0B | $-0.7B | $-4.6B | $-0.4B | $-1.2B | $-1.0B |
| Capital Expenditures | $1.0B | $1.0B | $0.8B | $0.7B | $0.6B | $0.5B | $0.8B | $0.8B |
| Financing Cash Flow | $-0.9B | $-2.0B | $-1.1B | $-0.8B | $1.6B | $-0.3B | $-1.3B | $-1.2B |